Alan S. Gamis
0000-0003-1513-2893
11 papers found
Refreshing results…
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation
CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children’s Oncology Group
Morphologic remission status is limited compared to ΔN flow cytometry: a Children’s Oncology Group AAML0531 report
Comprehensive characterization of pediatric AML reveals diverse fusion oncoproteins and age-specific mutational interactions
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children’s Oncology Group report
Missing publications? Search for publications with a matching author name.